
Transcarent
transcarent.comDeveloper of a consumer-directed health and care platform designed to facilitate improved outcomes and cost-effective decisions.
Last Round
Apr 2025
$20.48
Series D · $2.7B
Price per share
12M · USD
Loading chart...
Funding history
$M raised · $B post-money
Loading chart...
Explore related companies
More company profiles from the LBX Pro directory.